In addition, KM plotter survival curves demonstrated that among the patients with ACC (Figure 3(b), p = 0.01), BLCA (Figure 3(c), p = 0.013), CESC (Figure 3(d), p = 0.045), GBM (Figure 3(e), p = 0.037), KIRC (Figure 3(f), p = 0.002), KIRP (Figure 3(g), p = 0.012), acute myeloid leukemia (LAML) (Figure 3(h), p = 0.025), LGG (Figure 3(i), p < 0.001), MESO (Figure 3(j), p < 0.001), SKCM (Figure 3(k), p = 0.005), and UVM (Figure 3(l), p = 0.023), those with high COL5A1 expression experienced a shorter survival. This evidence concerns the gene COL5A1 and glioblastoma.